Ospedale Niguarda Ca' Granda, best known simply as Ospedale Niguarda or Niguarda Hospital is largest and one of the most important hospitals in Milan, Italy.

During the past decade, Ospedale Niguarda-Ca Granda, Dept. of Internal Medicine Padiglione Brera conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Ospedale Niguarda-Ca Granda, Dept. of Internal Medicine Padiglione Brera" are "Aspergillosis" (1 trials) and "Candidiasis" (1 trials). Many other conditions were trialed in "Ospedale Niguarda-Ca Granda, Dept. of Internal Medicine Padiglione Brera" in a lesser frequency.

Most popular intervention types in "Ospedale Niguarda-Ca Granda, Dept. of Internal Medicine Padiglione Brera" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "FK463" (2 trials). Other intervention names were less common.

The vast majority of trials in "Ospedale Niguarda-Ca Granda, Dept. of Internal Medicine Padiglione Brera" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Ospedale Niguarda-Ca Granda, Dept. of Internal Medicine Padiglione Brera". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Ospedale Niguarda-Ca Granda, Dept. of Internal Medicine Padiglione Brera, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Ospedale Niguarda-Ca Granda, Dept. of Internal Medicine Padiglione Brera, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".